These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5507632)

  • 1. Urinary metabolities of harmine in the rat and their inhibition of monoamine oxidase.
    Slotkin T; DiStefano V
    Biochem Pharmacol; 1970 Jan; 19(1):125-31. PubMed ID: 5507632
    [No Abstract]   [Full Text] [Related]  

  • 2. A model of harmine metabolism in the rat.
    Slotkin TA; DiStefano V
    J Pharmacol Exp Ther; 1970 Sep; 174(3):456-62. PubMed ID: 5456178
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood levels and urinary excretion of harmine and its metabolites in man and rats.
    Slotkin TA; DiStefano V; Au WY
    J Pharmacol Exp Ther; 1970 May; 173(1):26-30. PubMed ID: 5442301
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of mitochondrial monoamine oxidase of the rat uterus and liver by clorglyine, pargyline and harmine.
    Grosso DS; Gawienowski AM
    Biochem Pharmacol; 1976 Apr; 25(8):957-61. PubMed ID: 178322
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of harmaline in rats.
    Ho BT; Estevez V; Fritchie GE; Tansey LW; Idänpään-Heikkilä J; McIsaac WM
    Biochem Pharmacol; 1971 Jun; 20(6):1313-9. PubMed ID: 5118126
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitors of monoamine oxidase IV. 6(or 8)-Substituted tetrahydro-beta-carbolines and their 9-methyl analogs.
    Ho BT; McIsaac WM; Tansey LW
    J Pharm Sci; 1969 Aug; 58(8):998-1001. PubMed ID: 5344539
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of harmine and other monoamine oxidase inhibitors on N-acetyltransferase activity.
    Wright EE; Bird JL; Feldman JM
    Res Commun Chem Pathol Pharmacol; 1979 May; 24(2):259-72. PubMed ID: 461984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of 5,7-dinitroindazole in the mouse and the rat.
    Woolhouse NM; Kaye B; Monro AM; Parke DV
    Xenobiotica; 1973 Aug; 3(8):511-24. PubMed ID: 4797191
    [No Abstract]   [Full Text] [Related]  

  • 9. UDP glucuronyltransferase and phenolsulfotransferase from rat liver in vivo and in vitro--IV. Species differences in harmol conjugation and elimination in bile and urine in vivo.
    Mulder GJ; Bleeker B
    Biochem Pharmacol; 1975 Aug; 24(16):1481-4. PubMed ID: 811225
    [No Abstract]   [Full Text] [Related]  

  • 10. UDP glucuronyltransferase and phenolsulfotransferase in vivo and in vitro. Conjugation of harmol and harmalol.
    Mulder GJ; Hagedoorn AH
    Biochem Pharmacol; 1974 Aug; 23(15):2101-9. PubMed ID: 4213525
    [No Abstract]   [Full Text] [Related]  

  • 11. Guanylhydrazones, another class of monoamine oxidase inhibitors.
    Mutschler E; Springer J; Wassermann O
    Biochem Pharmacol; 1970 Jan; 19(1):9-15. PubMed ID: 5507652
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the in vitro conversion of monoamine oxidase into an enzyme resembling diamine oxidase].
    Gorkin VZ; Tat'ianenko LV; Moskvitina TA
    Biokhimiia; 1968; 33(2):393-402. PubMed ID: 4969636
    [No Abstract]   [Full Text] [Related]  

  • 13. Gas chromatographic determination of ibogaine in biological fluids.
    Cartoni GP; Giarusso A
    J Chromatogr; 1972 Aug; 71(1):154-8. PubMed ID: 5056243
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification of cytochrome c with N-methyl-N'-nitro-N-nitrosoguanidine.
    Nagao M; Hosoi H; Sugimura T
    Biochim Biophys Acta; 1971 May; 237(2):369-77. PubMed ID: 4328398
    [No Abstract]   [Full Text] [Related]  

  • 15. On the substrate-binding sites of the active centre of mitochondrial monoamine oxidase.
    Severina IS
    Eur J Biochem; 1973 Oct; 38(2):239-46. PubMed ID: 4773873
    [No Abstract]   [Full Text] [Related]  

  • 16. [The importance of substrate structure in selective inhibition of mitochondrial monoamine oxidase activity by several inhibitors].
    Severina IS
    Biokhimiia; 1973; 38(3):608-15. PubMed ID: 4798599
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluorescence microscopic study on rat brain neurons affected by harmaline administration.
    Bartonícek VJ
    Pharmacology; 1971; 5(1):36-42. PubMed ID: 5552259
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of monoamine oxidase by N-(phenoxyethyl)cyclopropylamines. Correlation of inhibition with Hammett constants and partition coefficients.
    Fuller RW; Marsh MM; Mills J
    J Med Chem; 1968 Mar; 11(2):397-8. PubMed ID: 5663643
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine.
    Fuller RW
    Biochem Pharmacol; 1968 Oct; 17(10):2097-106. PubMed ID: 5696879
    [No Abstract]   [Full Text] [Related]  

  • 20. [Kinetics of the inhibition of mitochondrial monoamine oxidases A and B from rat liver by 1-(indolyl-3)isopropylmethylpropargylamine].
    Gridneva LI; Dolicheva IN; Gorkin VZ; Smushkevich IuI; Suvorov NN
    Biokhimiia; 1983 Jul; 48(7):1122-8. PubMed ID: 6615922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.